Enduring behavioral effects of early exposure to methylphenidate in rats

Biological Psychiatry

Volumn 54, Issue 12, 2003, Pages 1330-1337

  Carlezon Jr , William A ^a   Mague, Stephen D ^a   Andersen, Susan L ^a   Carlezon, Bill ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Addiction; Anxiety; Cocaine; Depression; Development; Methylphenidate; Rat

Indexed keywords

COCAINE; METHYLPHENIDATE;

ADAPTIVE BEHAVIOR; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENUATION; AVERSION; BEHAVIOR DISORDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DRUG SENSITIVITY; FEMALE; FORCED SWIMMING TEST; HABITUATION; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

EID: 0346599159     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.08.020     Document Type: Article

References (49)

1. Andersen S.L., Arvanitogiannis A., Pliakas A.M., LeBlanc C., Carlezon W.A. Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nature Neurosci. 5:2002;13-14.
2. Andersen S.L., Thompson A.P., Krenzel E., Teicher M.H. Pubertal changes in gonadal hormones do not underlie adolescent dopamine receptor overproduction. Psychoneuroendocrinology. 27:2002;683-691.
3. Biederman J., Wilens T., Mick E., Spencer T., Faraone S.V. Pharmacotherapy of attention deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics. 104:1999;e20.
4. Bolaños CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003): Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54:1317-1329.
5. Brandon C.L., Marinelli M., Baker L.K., White F.J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacol. 25:2001;651-661.
6. Busidan Y., Dow-Edwards D.L. Behavioral sensitization to apomorphine in adult rats exposed to cocaine during the preweaning period A preliminary study . Pharmacol Biochem Behav. 63:1999;417-421.
7. Carlezon W.A. Jr, Boundy V.A., Haile C.N., Lane S.B., Kalb R.G., Neve R.L., Nestler E.J. Sensitization to morphine induced by viral-mediated gene transfer. Science. 277:1997;812-814.
8. Carlezon W.A. Jr, Nestler E.J. Elevated levels of GluR1 in the midbrain A trigger for sensitization to drugs of abuse? Trends Neurosci. 25:2002;610-615.
9. Carlezon W.A. Jr, Pliakas A.M., Parow A.M., Detke M.J., Cohen B.M., Renshaw P.F. Antidepressant-like effects of cytidine in the forced swim test in rats. Biol Psychiatry. 51:2002;882-889.
10. Carlezon W.A. Jr, Thome J., Olson V., Lane-Ladd S.B., Brodkin E.S., Hiroi N., et al. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
11. Carr G.D., Fibiger J.C., Phillips A.G. Conditioned place preference as a measure of drug reward. Liebman J.M., Cooper S.J. The Neuropharmacological Basis of Reward. 1989;264-319 Clarendon, Oxford.
12. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacol. 121:1995;66-72.
13. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A. 85:1988;5274-5278.
14. Horger B.A., Giles M.K., Schenk S. Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacol. 107:1992;271-276.
15. Horger B.A., Shelton K., Schenk S. Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav. 37:1990;707-711.
16. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev. 16:1991;223-244.
17. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacol. 24:2001;97-129.
18. Kuczenski R., Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine Comparison with amphetamine . J Neurochem. 68:1997;2032-2037.
19. Kuczenski R., Segal D.S. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate Relative roles of dopamine and norepinephrine . J Pharmacol Exper Ther. 296:2001;876-883.
20. Kuczenski R., Segal D.S. Exposure of adolescent rats to oral methylphenidate Preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine . J Neurosci. 22:2002;7264-7271.
21. Lett B.T. Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacol. 98:1989;357-362.
22. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, et al (2003): Antidepressant-like effects of kappa opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330.
23. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
24. Nestler E.J. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2:2001;119-128.
25. Overstreet D.H., Pucilowski O., Rezvani A.H., Janowsky D.S. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression. Psychopharmacol. 121:1995;27-37.
26. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
27. Pliakas A.M., Carlson R., Neve R.L., Konradi C., Nestler E.J., Carlezon W.A. Jr. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element binding protein expression in nucleus accumbens. J Neurosci. 21:2001;7397-7403.
28. Pontieri F.E., Tanda G., Orzi F., Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 382:1996;255-257.
29. Porsolt R.D., Le Pichon M., Jalfre M. Depression A new animal model sensitive to antidepressant treatments . Nature. 266:1977;730-732.
30. Post R.M., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature. 260:1976;731-732.
31. Ritz M.C., Kuhar M.J. Relationship between self-administration of amphetamine and monoamine receptors in brain Comparison with cocaine . J Pharmacol Exp Ther. 248:1989;1010-1017.
32. Robbins T.W. The 5-choice serial reaction time task Behavioural pharmacology and functional neurochemistry . Psychopharmacol. 163:2002;362-380.
33. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration A review and evaluation of animal models of amphetamine psychosis . Brain Res. 396:1986;157-198.
34. Robinson T.E., Berridge K.C. The psychology and neurobiology of addiction An incentive-sensitization view . Addiction. 95:2000;S91-S117.
35. Segal D.S., Mandell A.J. Long-term administration of d-amphetamine Progressive augmentation of motor activity and stereotypy . Pharmacol Biochem Behav. 2:1974;249-255.
36. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev. 81:1974;119-145.
37. Spencer T., Biederman J., Wilens T., Harding M., O'Donnell D., Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 35:1996;343-351.
38. Strakowski S.M., Sax K.W. Progressive behavioral response to repeated D-amphetamine challenge Further evidence for sensitization in humans . Biol Psychiatry. 44:1998;1171-1177.
39. Swanson J.M., Seargeant J.A., Taylor E., Sonuga-Barke E.J.S., Jensen P.S., Cantwell D.P. Attention deficit disorder and hyperkinetic disorder. Lancet. 351:1998;429-433.
40. Taylor F.B., Russo J. Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 21:2001;223-228.
41. Teicher M.H., Andersen S.L., Wallace P., Klein D.A., Hostetter J. Development of an affordable hi-resolution activity monitor system for laboratory animals. Pharmacol Biochem Behav. 54:1996;479-483.
42. Teicher M.H., Ito Y., Glod C.A., Barber N.I. Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry. 35:1996;334-342.
43. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization A critical review of preclinical studies . Psychopharmacol. 151:2000;99-120.
44. Volkow N.D., Wang G., Fowler J.S., Logan J., Gerasimov M., Maynard L., et al. Therapeutic doses of oral methylphenidate significantly increases extracellular dopamine in the human brain. J Neurosci. 21:2001;RC121.
45. Wargin W., Kilts P.C., Gualtieri C.T., Ellington K.R., Mueller R.A., Kraemer G., Breese G.R. Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther. 226:1983;382-386.
46. Wilens T.E., Faraone S.V., Biederman J., Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 111:2003;179-185.
47. Willner P. The validity of animal models of depression. Psychopharmacol. 83:1984;1-16.
48. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev. 94:1987;469-492.
49. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 283:2000;1025-1030.